Prognostic significance of cardiovascular biomarkers and renal dysfunction in outpatients with systolic heart failure: A long term follow-up study

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages 202-207

  Bosselmann, Helle ^a   Egstrup, Michael ^b   Rossing, Kasper ^c   Gustafsson, Ida ^d   Gustafsson, Finn ^c   Tonder, Niels ^a   Kistorp, Caroline N ^e   Goetze, Jens P ^c   Schou, Morten ^a  

^a HILLERØD HOSPITAL   (Denmark)

^b FREDERIKSBERG HOSPITAL   (Denmark)

^c University of Copenhagen   (Denmark)

^d HVIDOVRE HOSPITAL   (Denmark)

^e GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Cardiovascular biomarkers; Mortality risk; Renal function; Systolic heart failure

Indexed keywords

ADRENOMEDULLIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; COPEPTIN; PROADRENOMEDULLIN; TROPONIN T;

ADULT; AGED; ARTICLE; CAUSE OF DEATH; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTPATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SURVIVAL RATE; SYSTOLIC HEART FAILURE;

CARDIOVASCULAR BIOMARKERS; MORTALITY RISK; RENAL FUNCTION; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, SYSTOLIC; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; NEOSTIGMINE; PEPTIDE FRAGMENTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; TROPONIN T;

EID: 84889091320     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.064     Document Type: Article

References (32)

1. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation, and survival in patients with chronic heart failure Circulation 102 2000 203 210
2. R. de Silva, N.P. Nikitin, and K.K. Witte Incidence of renal dysfunction over 6 months in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis Eur Heart J 27 2006 569 581
3. H.L. Hillege, D. Nitsch, and M.A. Pfeffer Renal function as a predictor of outcome in a broad spectrum of patients with heart failure Circulation 113 2006 671 678
4. C. Adlbrecht, M. Hulsmann, and G. Strunk Prognostic value of plasma midregional pro-adrenomedullin and c-terminal-pro-endothelin-1 in chronic heart failure outpatients Eur J Heart Fail 11 2009 361 366
5. B. Stoiser, D. Mortl, and M. Hulsmann Copeptin, a fragment of the vasopressin precursor, as a novel predictor of outcome in heart failure Eur J Clin Invest 36 2006 771 778
6. T. Tsutamoto, C. Kawahara, and M. Yamaji Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure Eur J Heart Fail 11 2009 653 658
7. T. Tsutamoto, A. Wada, and H. Sakai Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure J Am Coll Cardiol 47 2006 582 586
8. J.P. Goetze, G. Jensen, S. Moller, F. Bendtsen, J.F. Rehfeld, and J.H. Henriksen BNP and N-terminal proBNP are both extracted in the normal kidney Eur J Clin Invest 36 2006 8 15
9. S. Galatius, F. Gustafsson, P. Nielsen, D. Atar, and P. Hildebrandt An integrated approach to diagnosis and therapeutic management of patients with systolic heart failure in the Copenhagen metropolitan area Am Heart J 144 2002 E2
10. U. Alehagen, U. Dahlström, J.F. Rehfeld, and J.P. Goetze Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements Clin Chem 56 2010 1718 1724
11. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin Clin Chem 52 2006 112 119
12. N.G. Morgenthaler, J. Struck, B. Thomas, and A. Bergmann Immunoluminometric assay for the midregion of pro-atrial natriuretic peptide in human plasma Clin Chem 50 2004 234 236
13. N.G. Morgenthaler, J. Struck, C. Alonso, and A. Bergmann Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay Clin Chem 51 2005 1823 1829
14. Andrew S. Levey, J.P. Bosch, Julia Breyer Lewis, Tom Greene, Nancy Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine a new prediction equation. Modification of diet in renal disease study group Ann Intern Med 130 1999 461 470
15. M. Metra, G. Cotter, M. Gheorghiade, L. Dei Cas, and A.A. Voors The role of the kidney in heart failure Eur Heart J 33 2012 2135 2142
16. T.D. Smilde, K. Damman, and P. van der Harst Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure Clin Res Cardiol 98 2009 121 129
17. S. Ljungman, J.H. Laragh, and R.J. Cody Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function Drugs 39 Suppl. 4 1990 10 21 [discussion 22-14]
18. B.M. Massie, C.M. O'Connor, and M. Metra Rolofylline, an adenosine a1-receptor antagonist, in acute heart failure N Engl J Med 363 2010 1419 1428
19. G. Boerrigter, L.C. Costello-Boerrigter, and W.T. Abraham Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rate J Card Fail 14 2008 539 546
20. R. de Silva, N.P. Nikitin, and K.K. Witte Effects of applying a standardised management algorithm for moderate to severe renal dysfunction in patients with chronic stable heart failure Eur J Heart Fail 9 2007 415 423
21. S. Lekawanvijit, A. Adrahtas, D.J. Kelly, A.R. Kompa, B.H. Wang, and H. Krum Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J 31 2010 1771 1779
22. M. Schou, F. Gustafsson, C.N. Kistorp, P. Corell, A. Kjaer, and P.R. Hildebrandt Effects of body mass index and age on n-terminal pro brain natriuretic peptide are associated with glomerular filtration rate in chronic heart failure patients Clin Chem 53 2007 1928 1935
23. H.L. Hillege, A.R. Girbes, and P.J. de Kam Renal function, neurohormonal activation and survival in patients with chronic heart failure Circulation 102 2000 203 210
24. M. Schou, M.K. Dalsgaard, and O. Clemmesen Kidneys extract BNP and NT-proBNP in healthy young men J Appl Physiol 99 2005 1676 1680
25. C.M. O'Connor, R.C. Starling, and A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
26. M.A. Konstam, M. Gheorghiade, and J.C. Burnett Jr. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST outcome trial JAMA 297 2007 1319 1331
27. M. Packer, R.M. Califf, and M.A. Konstam Comparison of omapatrilat and enalapril in patients with chronic heart failure: the omapatrilat versus enalapril randomized trial of utility in reducing events (overture) Circulation 106 2002 920 926
28. L.M. Ruilope, A. Dukat, M. Bohm, Y. Lacourciere, J. Gong, and M.P. Lefkowitz Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin ii receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study Lancet 375 2010 1255 1266
29. M.T. Rademaker, C.J. Charles, E.A. Espiner, M.G. Nicholls, and A.M. Richards Long-term adrenomedullin administration in experimental heart failure Hypertension 40 2002 667 672
30. T.D. Smilde, D.J. van Veldhuisen, G. Navis, A.A. Voors, and H.L. Hillege Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction Circulation 114 2006 1572 1580
31. K. Damman, S. Masson, and H.L. Hillege Clinical outcome of renal tubular damage in chronic heart failure Eur Heart J 32 2011 2705 2712
32. K. Damman, H.L. Hillege, and D.J. van Veldhuisen Albuminuria in heart failure: a charming new risk factor? Lancet 374 2009 506 508